Mobia Medical, Inc. Common Stock (NASDAQ:MOBI) — Market Cap & Net Worth
Market Cap & Net Worth: Mobia Medical, Inc. Common Stock (MOBI)
Mobia Medical, Inc. Common Stock (NASDAQ:MOBI) has a market capitalization of $419.60 Million ($419.60 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13304 globally and #3172 in its home market, demonstrating a 14.23% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mobia Medical, Inc. Common Stock's stock price $14.53 by its total outstanding shares 33249006 (33.25 Million). Review Mobia Medical, Inc. Common Stock total liabilities to assess the company's total debt and financial obligations.
Mobia Medical, Inc. Common Stock Market Cap History: 2026 to 2026
Mobia Medical, Inc. Common Stock's market capitalization history from 2026 to 2026. Data shows growth from $483.11 Million to $483.11 Million (0.00% CAGR).
Mobia Medical, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mobia Medical, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MOBI by Market Capitalization
Companies near Mobia Medical, Inc. Common Stock in the global market cap rankings as of June 18, 2026.
Key companies related to Mobia Medical, Inc. Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #149 globally with a market cap of $153.89 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #212 globally with a market cap of $115.24 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #252 globally with a market cap of $100.32 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #149 | Abbott Laboratories | NYSE:ABT | $153.89 Billion | $88.50 |
| #212 | Stryker Corporation | NYSE:SYK | $115.24 Billion | $301.14 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #252 | Medtronic PLC | NYSE:MDT | $100.32 Billion | $78.14 |
Mobia Medical, Inc. Common Stock Historical Marketcap From 2026 to 2026
Between 2026 and today, Mobia Medical, Inc. Common Stock's market cap moved from $483.11 Million to $ 483.11 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $483.11 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Mobia Medical, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $419.60 Million USD |
| MoneyControl | $419.60 Million USD |
| MarketWatch | $419.60 Million USD |
| marketcap.company | $419.60 Million USD |
| Reuters | $419.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Mobia Medical, Inc. Common Stock
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable devi… Read more